News und Analysen
EQS-News: AIXTRON well on track in a challenging market environment
EQS-News: AIXTRON well on track in a challenging market environment
EQS-News: SIXT exceeds the four-billion-euro revenue mark for the first time: third record year in a row
EQS-News: SIXT exceeds the four-billion-euro revenue mark for the first time: third record year in a row
EQS-News: Nordex Group achieves all 2024 financial and operational targets, reporting substantial increase in profitability
EQS-News: Nordex Group achieves all 2024 financial and operational targets, reporting substantial increase in profitability
EQS-News: Nordex Group achieves all 2024 financial and operational targets, reporting substantial increase in profitability
EQS-News: Nordex Group achieves all 2024 financial and operational targets, reporting substantial increase in profitability
EQS-News: FORVIA HELLA presents preliminary results for fiscal year 2024 and outlook for 2025
EQS-News: FORVIA HELLA presents preliminary results for fiscal year 2024 and outlook for 2025
EQS-News: Changes in the Executive Board: CEWE Stiftung & Co. KGaA prepares for the future
EQS-News: Changes in the Executive Board: CEWE Stiftung & Co. KGaA prepares for the future
EQS-News: KION with strong financial year 2024: significant increase in profitability
EQS-News: KION with strong financial year 2024: significant increase in profitability
EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf announces another share buyback program
EQS-Adhoc: Beiersdorf Aktiengesellschaft: Beiersdorf announces another share buyback program
EQS-Adhoc: CEWE Stiftung & Co. KGaA: Management changes at CEWE
EQS-Adhoc: CEWE Stiftung & Co. KGaA: Management changes at CEWE
Succession in the Chairmanship of the Supervisory Board of AIXTRON SE
Succession in the Chairmanship of the Supervisory Board of AIXTRON SE
Succession in the Chairmanship of the Supervisory Board of AIXTRON SE
Succession in the Chairmanship of the Supervisory Board of AIXTRON SE
EQS-News: FUCHS opens expanded plant in South Africa to meet growing demand
EQS-News: FUCHS opens expanded plant in South Africa to meet growing demand
EQS-News: Evotec announces change in Management Board
EQS-News: Evotec announces change in Management Board
EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
EQS-News: Gerresheimer delivers solid results in the financial year 2024 despite market headwinds
EQS-News: E.ON concludes fiscal year with strong earnings and record investments in the energy transition
EQS-News: E.ON concludes fiscal year with strong earnings and record investments in the energy transition
EQS-News: Preliminary results for FY 2024: TAG Immobilien AG exceeds guidance
EQS-News: Preliminary results for FY 2024: TAG Immobilien AG exceeds guidance
EQS-Adhoc: TAG Immobilien AG: Net income from sales in Poland and FFO II significantly exceed guidance for FY 2024
EQS-Adhoc: TAG Immobilien AG: Net income from sales in Poland and FFO II significantly exceed guidance for FY 2024
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re plans dividend of €20 per share for 2024 and resolves share buy-back with volume of up to €2.0bn
EQS-Adhoc: Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Munich Re plans dividend of €20 per share for 2024 and resolves share buy-back with volume of up to €2.0bn
EQS-News: CEWE: Turnover and earnings increased further, targets achieved
EQS-News: CEWE: Turnover and earnings increased further, targets achieved
EQS-News: HAMBORNER REIT AG publishes preliminary figures – stable and planned business development in 2024 – Dividend proposal at previous year's level
EQS-News: HAMBORNER REIT AG publishes preliminary figures – stable and planned business development in 2024 – Dividend proposal at previous year's level
Is Merck Stock a Buy?
It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates with
EQS-Adhoc: Publication of Annual Report 2024 on 10 April 2025 due to a retrospective adjustment of the comparison periods 2022 and 2023 – FY 2024 EBITDA in the middle of guidance range of EUR 30 – 60m
EQS-Adhoc: Publication of Annual Report 2024 on 10 April 2025 due to a retrospective adjustment of the comparison periods 2022 and 2023 – FY 2024 EBITDA in the middle of guidance range of EUR 30 – 60m
EQS-News: adesso increases sales in 2024 to approx. EUR 1.3 billion (+14 %) / EBITDA improves by +23 % to approx. EUR 98.3 million / Dividend increase to EUR 0.75 / Positive margin trend also planned for 2025
EQS-News: adesso increases sales in 2024 to approx. EUR 1.3 billion (+14 %) / EBITDA improves by +23 % to approx. EUR 98.3 million / Dividend increase to EUR 0.75 / Positive margin trend also planned for 2025
EQS-News: Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC
EQS-News: Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC